US Stock MarketDetailed Quotes

Protagonist Therapeutics (PTGX)

Watchlist

98.370
-2.370-2.35%

Close May 19 15:59 ET

97.360
-1.010-1.03%

Pre 04:01 ET

6.33BMarket Cap-54.35P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Protagonist Therapeutics (PTGX) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-139.04%-48.94M

-68.68%57.67M

-26.72%-36.98M

93.05%-1.94M

-110.71%-28.78M

557.05%125.36M

362.19%184.15M

-272.04%-29.18M

-4.70%-27.86M

1,123.79%268.62M

Net income from continuing operations

132.46%3.78M

-147.29%-130.15M

-133.71%-44.38M

-18.46%-39.34M

-13.57%-34.77M

-105.62%-11.66M

448.54%275.19M

381.70%131.67M

2.62%-33.21M

20.40%-30.62M

Operating gains losses

-140.00%-2K

----

---1K

--0

--5K

----

Depreciation and amortization

70.29%407K

54.96%1.28M

218.64%376K

56.28%361K

26.14%304K

1.27%239K

-15.46%826K

-52.42%118K

-5.33%231K

1.69%241K

Other non cash items

-22.85%439K

-23.63%1.58M

-19.38%337K

-74.52%106K

-12.75%568K

-2.57%569K

-18.19%2.07M

-28.42%418K

-28.64%416K

11.47%651K

Change In working capital

-153.78%-67.06M

219.25%146.21M

98.41%-2.67M

1,168.18%28.06M

-101.33%-3.88M

151.24%124.69M

-528.41%-122.61M

-918.96%-167.72M

-389.32%-2.63M

7,144.00%291.06M

-Change in receivables

-137.66%-53.54M

206.37%164.88M

100.28%462K

50,374.42%21.7M

-99.82%538K

149.02%142.18M

-1,451.55%-155M

-1,550.00%-165M

10.26%43K

2,499,900.00%300M

-Change in prepaid assets

-102.32%-1.92M

37.37%-2.36M

-214.06%-365K

104.30%50K

45.42%-1.1M

-3.61%-948K

-314.95%-3.77M

87.13%320K

-84.90%-1.16M

-241.15%-2.01M

-Change in payables and accrued expense

31.56%-7.79M

-28.23%5.61M

48.40%5.1M

198.83%9.96M

186.09%1.93M

-446.85%-11.38M

191.63%7.82M

157.93%3.44M

52.17%3.33M

-168.55%-2.24M

-Change in other current liabilities

-260.41%-547K

59.43%-903K

49.35%-426K

-250.00%-581K

54.68%-237K

148.99%341K

18.85%-2.23M

-20.83%-841K

76.05%-166K

23.09%-523K

-Change in other working capital

40.54%-3.27M

-168.76%-21.02M

-31.93%-7.44M

34.22%-3.08M

-20.18%-5.01M

-112.20%-5.5M

--30.57M

---5.64M

---4.68M

---4.17M

Cash from discontinued investing activities

Operating cash flow

-139.04%-48.94M

-68.68%57.67M

-26.72%-36.98M

93.05%-1.94M

-110.71%-28.78M

557.05%125.36M

362.19%184.15M

-272.04%-29.18M

-4.70%-27.86M

1,123.79%268.62M

Investing cash flow

Cash flow from continuing investing activities

196.28%90.89M

83.53%-49.33M

659.48%48.82M

71.94%-58.56M

162.20%54.81M

-1,654.97%-94.4M

-662.86%-299.48M

85.76%-8.73M

-1,439.27%-208.71M

-442.05%-88.12M

Net PPE purchase and sale

60.55%-215K

-17.34%-1.59M

53.55%-144K

88.65%-88K

-2,803.57%-813K

-125.21%-545K

-122.50%-1.36M

-1,531.58%-310K

-91.83%-775K

84.09%-28K

Net investment purchase and sale

197.07%91.11M

83.99%-47.74M

681.81%48.96M

71.88%-58.47M

163.14%55.62M

-1,586.73%-93.86M

-671.37%-298.13M

86.27%-8.42M

-1,480.65%-207.94M

-439.62%-88.09M

Cash from discontinued investing activities

Investing cash flow

196.28%90.89M

83.53%-49.33M

659.48%48.82M

71.94%-58.56M

162.20%54.81M

-1,654.97%-94.4M

-662.86%-299.48M

85.76%-8.73M

-1,439.27%-208.71M

-442.05%-88.12M

Financing cash flow

Cash flow from continuing financing activities

104.26%23.37M

-11.56%22.86M

-29.62%2.84M

-53.04%5.66M

13.72%2.93M

58.95%11.44M

-84.83%25.85M

664.90%4.03M

-65.88%12.05M

-97.62%2.57M

Net common stock issuance

----

--0

----

--0

Proceeds from stock option exercised by employees

96.06%23.37M

-11.76%23.34M

-29.62%2.84M

-53.04%5.66M

13.72%2.93M

52.87%11.92M

-32.42%26.45M

676.69%4.03M

-65.95%12.05M

164.34%2.57M

Net other financing activities

----

20.17%-479K

--0

20.17%-479K

21.98%-600K

--0

Cash from discontinued financing activities

Financing cash flow

104.26%23.37M

-11.56%22.86M

-29.62%2.84M

-53.04%5.66M

13.72%2.93M

58.95%11.44M

-84.83%25.85M

664.90%4.03M

-65.88%12.05M

-97.62%2.57M

Net cash flow

Beginning cash position

32.01%128.68M

-47.86%97.47M

-13.21%114M

-52.56%168.83M

-19.05%139.88M

-47.86%97.47M

48.41%186.95M

-43.08%131.35M

51.04%355.87M

35.09%172.79M

Current changes in cash

54.05%65.32M

134.87%31.2M

143.33%14.68M

75.58%-54.83M

-84.18%28.96M

399.48%42.4M

-246.73%-89.48M

22.67%-33.87M

-4,524.55%-224.52M

69.99%183.08M

Effect of exchange rate changes

----

--0

----

End cash Position

38.69%194M

32.01%128.68M

-13.21%114M

-52.56%168.83M

-19.05%139.88M

-47.86%97.47M

-43.08%131.35M

51.04%355.87M

Free cash flow

-139.38%-49.16M

-69.32%56.08M

-25.88%-37.12M

92.93%-2.03M

-111.02%-29.59M

551.08%124.82M

358.02%182.8M

-274.06%-29.49M

-6.01%-28.64M

1,116.86%268.59M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-139.04%-48.94M	-68.68%57.67M	-26.72%-36.98M	93.05%-1.94M	-110.71%-28.78M	557.05%125.36M	362.19%184.15M	-272.04%-29.18M	-4.70%-27.86M	1,123.79%268.62M
Net income from continuing operations	132.46%3.78M	-147.29%-130.15M	-133.71%-44.38M	-18.46%-39.34M	-13.57%-34.77M	-105.62%-11.66M	448.54%275.19M	381.70%131.67M	2.62%-33.21M	20.40%-30.62M
Operating gains losses	-140.00%-2K	----	----	---1K	--0	--5K	----	----	----	----
Depreciation and amortization	70.29%407K	54.96%1.28M	218.64%376K	56.28%361K	26.14%304K	1.27%239K	-15.46%826K	-52.42%118K	-5.33%231K	1.69%241K
Other non cash items	-22.85%439K	-23.63%1.58M	-19.38%337K	-74.52%106K	-12.75%568K	-2.57%569K	-18.19%2.07M	-28.42%418K	-28.64%416K	11.47%651K
Change In working capital	-153.78%-67.06M	219.25%146.21M	98.41%-2.67M	1,168.18%28.06M	-101.33%-3.88M	151.24%124.69M	-528.41%-122.61M	-918.96%-167.72M	-389.32%-2.63M	7,144.00%291.06M
-Change in receivables	-137.66%-53.54M	206.37%164.88M	100.28%462K	50,374.42%21.7M	-99.82%538K	149.02%142.18M	-1,451.55%-155M	-1,550.00%-165M	10.26%43K	2,499,900.00%300M
-Change in prepaid assets	-102.32%-1.92M	37.37%-2.36M	-214.06%-365K	104.30%50K	45.42%-1.1M	-3.61%-948K	-314.95%-3.77M	87.13%320K	-84.90%-1.16M	-241.15%-2.01M
-Change in payables and accrued expense	31.56%-7.79M	-28.23%5.61M	48.40%5.1M	198.83%9.96M	186.09%1.93M	-446.85%-11.38M	191.63%7.82M	157.93%3.44M	52.17%3.33M	-168.55%-2.24M
-Change in other current liabilities	-260.41%-547K	59.43%-903K	49.35%-426K	-250.00%-581K	54.68%-237K	148.99%341K	18.85%-2.23M	-20.83%-841K	76.05%-166K	23.09%-523K
-Change in other working capital	40.54%-3.27M	-168.76%-21.02M	-31.93%-7.44M	34.22%-3.08M	-20.18%-5.01M	-112.20%-5.5M	--30.57M	---5.64M	---4.68M	---4.17M
Cash from discontinued investing activities
Operating cash flow	-139.04%-48.94M	-68.68%57.67M	-26.72%-36.98M	93.05%-1.94M	-110.71%-28.78M	557.05%125.36M	362.19%184.15M	-272.04%-29.18M	-4.70%-27.86M	1,123.79%268.62M
Investing cash flow
Cash flow from continuing investing activities	196.28%90.89M	83.53%-49.33M	659.48%48.82M	71.94%-58.56M	162.20%54.81M	-1,654.97%-94.4M	-662.86%-299.48M	85.76%-8.73M	-1,439.27%-208.71M	-442.05%-88.12M
Net PPE purchase and sale	60.55%-215K	-17.34%-1.59M	53.55%-144K	88.65%-88K	-2,803.57%-813K	-125.21%-545K	-122.50%-1.36M	-1,531.58%-310K	-91.83%-775K	84.09%-28K
Net investment purchase and sale	197.07%91.11M	83.99%-47.74M	681.81%48.96M	71.88%-58.47M	163.14%55.62M	-1,586.73%-93.86M	-671.37%-298.13M	86.27%-8.42M	-1,480.65%-207.94M	-439.62%-88.09M
Cash from discontinued investing activities
Investing cash flow	196.28%90.89M	83.53%-49.33M	659.48%48.82M	71.94%-58.56M	162.20%54.81M	-1,654.97%-94.4M	-662.86%-299.48M	85.76%-8.73M	-1,439.27%-208.71M	-442.05%-88.12M
Financing cash flow
Cash flow from continuing financing activities	104.26%23.37M	-11.56%22.86M	-29.62%2.84M	-53.04%5.66M	13.72%2.93M	58.95%11.44M	-84.83%25.85M	664.90%4.03M	-65.88%12.05M	-97.62%2.57M
Net common stock issuance	----	--0	----	----	----	----	--0	--0	--0	--0
Proceeds from stock option exercised by employees	96.06%23.37M	-11.76%23.34M	-29.62%2.84M	-53.04%5.66M	13.72%2.93M	52.87%11.92M	-32.42%26.45M	676.69%4.03M	-65.95%12.05M	164.34%2.57M
Net other financing activities	----	20.17%-479K	--0	--0	--0	20.17%-479K	21.98%-600K	--0	--0	--0
Cash from discontinued financing activities
Financing cash flow	104.26%23.37M	-11.56%22.86M	-29.62%2.84M	-53.04%5.66M	13.72%2.93M	58.95%11.44M	-84.83%25.85M	664.90%4.03M	-65.88%12.05M	-97.62%2.57M
Net cash flow
Beginning cash position	32.01%128.68M	-47.86%97.47M	-13.21%114M	-52.56%168.83M	-19.05%139.88M	-47.86%97.47M	48.41%186.95M	-43.08%131.35M	51.04%355.87M	35.09%172.79M
Current changes in cash	54.05%65.32M	134.87%31.2M	143.33%14.68M	75.58%-54.83M	-84.18%28.96M	399.48%42.4M	-246.73%-89.48M	22.67%-33.87M	-4,524.55%-224.52M	69.99%183.08M
Effect of exchange rate changes	----	----	----	----	----	----	--0	----	----	----
End cash Position	38.69%194M	32.01%128.68M	32.01%128.68M	-13.21%114M	-52.56%168.83M	-19.05%139.88M	-47.86%97.47M	-47.86%97.47M	-43.08%131.35M	51.04%355.87M
Free cash flow	-139.38%-49.16M	-69.32%56.08M	-25.88%-37.12M	92.93%-2.03M	-111.02%-29.59M	551.08%124.82M	358.02%182.8M	-274.06%-29.49M	-6.01%-28.64M	1,116.86%268.59M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

On May 19, Eastern Time, Trump issued a clear countdown: 'in two or three days—maybe Friday, Saturday, Sunday, or early next week'—the U.S. Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm